280 related articles for article (PubMed ID: 17892155)
21. Engineering attenuated virus vaccines by controlling replication fidelity.
Vignuzzi M; Wendt E; Andino R
Nat Med; 2008 Feb; 14(2):154-61. PubMed ID: 18246077
[TBL] [Abstract][Full Text] [Related]
22. Canine respiratory viruses.
Buonavoglia C; Martella V
Vet Res; 2007; 38(2):355-73. PubMed ID: 17296161
[TBL] [Abstract][Full Text] [Related]
23. Safety and efficacy of vaccination of seronegative bulls with modified-live, cytopathic bovine viral diarrhea viruses.
Givens MD; Riddell KP; Zhang Y; Galik P; Walz PH; Brodersen BW; Johnson JW; Passler T; Widel P; Tremblay R
Theriogenology; 2009 Apr; 71(6):975-83. PubMed ID: 19144395
[TBL] [Abstract][Full Text] [Related]
24. Oral delivery of DNA vaccine encoding VP28 against white spot syndrome virus in crayfish by attenuated Salmonella typhimurium.
Ning JF; Zhu W; Xu JP; Zheng CY; Meng XL
Vaccine; 2009 Feb; 27(7):1127-35. PubMed ID: 19071178
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of an intranasal modified live bovine respiratory syncytial virus and temperature-sensitive parainfluenza type 3 virus vaccine in 3-week-old calves experimentally challenged with PI3V.
Vangeel I; Ioannou F; Riegler L; Salt JS; Harmeyer SS
Vet J; 2009 Jan; 179(1):101-8. PubMed ID: 17931918
[TBL] [Abstract][Full Text] [Related]
26. Recombination in the alphaherpesvirus bovine herpesvirus 1.
Thiry E; Muylkens B; Meurens F; Gogev S; Thiry J; Vanderplasschen A; Schynts F
Vet Microbiol; 2006 Mar; 113(3-4):171-7. PubMed ID: 16343820
[TBL] [Abstract][Full Text] [Related]
27. Plant-produced viral bovine vaccines: what happened during the last 10 years?
Ruiz V; Mozgovoj MV; Dus Santos MJ; Wigdorovitz A
Plant Biotechnol J; 2015 Oct; 13(8):1071-7. PubMed ID: 26250843
[TBL] [Abstract][Full Text] [Related]
28. Fetal protection against continual exposure to bovine viral diarrhea virus following administration of a vaccine containing an inactivated bovine viral diarrhea virus fraction to cattle.
Grooms DL; Bolin SR; Coe PH; Borges RJ; Coutu CE
Am J Vet Res; 2007 Dec; 68(12):1417-22. PubMed ID: 18052749
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of intradermally administrated E2 subunit vaccines in reducing horizontal transmission of classical swine fever virus.
Dortmans JC; Loeffen WL; Weerdmeester K; van der Poel WH; de Bruin MG
Vaccine; 2008 Feb; 26(9):1235-42. PubMed ID: 18242794
[TBL] [Abstract][Full Text] [Related]
30. Correlations between virus infection and pathogenicity in humans.
Agut H; Huraux JM
Dev Biol Stand; 1991; 75():211-7. PubMed ID: 1794623
[TBL] [Abstract][Full Text] [Related]
31. Classical swine fever virus strain "C" protects the offspring by oral immunisation of pregnant sows.
Kaden V; Lange E; Steyer H; Lange B; Klopfleisch R; Teifke JP; Bruer W
Vet Microbiol; 2008 Jul; 130(1-2):20-7. PubMed ID: 18321665
[TBL] [Abstract][Full Text] [Related]
32. A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics.
Hu S; Ma H; Wu Y; Liu W; Wang X; Liu Y; Liu X
Vaccine; 2009 Feb; 27(6):904-10. PubMed ID: 19095026
[TBL] [Abstract][Full Text] [Related]
33. Vaccine cell substrates: bovine and porcine virus considerations.
Wessman SJ
Dev Biol (Basel); 2006; 123():273-80; discussion 291-308. PubMed ID: 16566453
[TBL] [Abstract][Full Text] [Related]
34. Vaccines against dengue virus.
Woodland DL
Viral Immunol; 2015 Mar; 28(2):75. PubMed ID: 25689610
[No Abstract] [Full Text] [Related]
35. The challenge for the next generation of feline calicivirus vaccines.
Radford AD; Dawson S; Coyne KP; Porter CJ; Gaskell RM
Vet Microbiol; 2006 Oct; 117(1):14-8. PubMed ID: 16698199
[TBL] [Abstract][Full Text] [Related]
36. Viruses - from pathogens to vaccine carriers.
Small JC; Ertl HC
Curr Opin Virol; 2011 Oct; 1(4):241-5. PubMed ID: 22003377
[TBL] [Abstract][Full Text] [Related]
37. Absence of lumpy skin disease virus in semen of vaccinated bulls following vaccination and subsequent experimental infection.
Osuagwuh UI; Bagla V; Venter EH; Annandale CH; Irons PC
Vaccine; 2007 Mar; 25(12):2238-43. PubMed ID: 17250934
[TBL] [Abstract][Full Text] [Related]
38. High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus.
Brehm KE; Kumar N; Thulke HH; Haas B
Vaccine; 2008 Mar; 26(13):1681-7. PubMed ID: 18313814
[TBL] [Abstract][Full Text] [Related]
39. Cellular and cytokine responses in feathers of chickens vaccinated against Marek's disease.
Abdul-Careem MF; Hunter DB; Shanmuganathan S; Haghighi HR; Read L; Heidari M; Sharif S
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):362-6. PubMed ID: 18722673
[TBL] [Abstract][Full Text] [Related]
40. Localization of VP28 on the baculovirus envelope and its immunogenicity against white spot syndrome virus in Penaeus monodon.
Syed Musthaq S; Madhan S; Sahul Hameed AS; Kwang J
Virology; 2009 Sep; 391(2):315-24. PubMed ID: 19604531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
